NLEX Road Warriors reacquire Miranda !-- -- Olmin Leyba (The Philippine Star) - August 21, 2019 - 12:00am MANILA, Philippines NLEX bolstered its middle by reacquiring
former player Mike Miranda from NorthPort in exchange for guard Juami Tiongson.
Therefore, it is believed that reacquiring
of the government land from private ownership is rarely possible.
As its title declares, RA 9225 (which took effect in 2003) amends CA 63 by doing away with the provision in the old law which takes away Philippine citizenship from natural-born Filipinos who become naturalized citizens of other countries and allowing dual citizenship, and also provides for the procedure for reacquiring
and retaining Philippine citizenship.
The media giant made a preliminary inquiry about reacquiring
the rights, but met resistance, the report says.
When a recall is issued, the main concern is reacquiring
the affected product to prevent harm to the consumer.
Roque, in a statement, reiterated that the Palace will leave it to Congress to decide on how to proceed with reacquiring
During his visit to Washington earlier this month, Iqbal advised the embassy to negotiate a fresh deal with the United States for reacquiring
helicopters for his ministry.
the company, we need to focus on establishing our sales force.
During the discussion held on Wednesday 10 April, President Rajapaksa spoke to the delegation about the problem Sri Lanka is facing with regard to patent rights of various plants and herbs and requested assistance in reacquiring
those patent rights.
The company asserts its spectrum analyzers help users save time in instrument set-up and in reacquiring
signals by making front panel measurement easy through use of auto-functions, saving/recalling setups, traces and test states.
2 August 2010 - US biopharmaceutical company Lexicon Pharmaceuticals Inc (NASDAQ: LXRX) said Monday it has exercised a restructured purchase option under its drug development financing collaboration with Symphony Icon Holdings LLC and acquired all the equity of Symphony Icon Inc, thereby reacquiring
all rights to LX1031, LX1032, LX1033 and the other drug programmes subject to the collaboration.